Glyburide-induced	glyburide-induced	O	O
hepatitis	hepatitis	O	S_disease
.	.	O	O

Drug-induced	drug-induced	O	O
hepatotoxicity	hepatotoxicity	O	S_disease
,	,	O	O
although	although	O	O
common	common	O	O
,	,	O	O
has	has	O	O
been	been	O	O
reported	reported	O	O
only	only	O	O
infrequently	infrequently	O	O
with	with	O	O
sulfonylureas	sulfonylureas	O	O
.	.	O	O

For	for	O	O
glyburide	glyburide	O	O
,	,	O	O
a	a	O	O
second-generation	second-generation	O	O
sulfonylurea	sulfonylurea	O	O
,	,	O	O
only	only	O	O
two	two	O	O
brief	brief	O	O
reports	reports	O	O
of	of	O	O
hepatotoxicity	hepatotoxicity	O	S_disease
exist	exist	O	O
.	.	O	O

Two	two	O	O
patients	patients	O	O
with	with	O	O
type	type	O	O
II	ii	O	O
diabetes	diabetes	O	B_disease
mellitus	mellitus	O	I_disease
developed	developed	O	O
an	an	O	O
acute	acute	O	B_disease
hepatitis-like	hepatitis-like	O	I_disease
syndrome	syndrome	O	I_disease
soon	soon	O	O
after	after	O	O
initiation	initiation	O	O
of	of	O	O
glyburide	glyburide	O	O
therapy	therapy	O	O
.	.	O	O

There	there	O	O
was	was	O	O
no	no	O	O
serologic	serologic	O	O
evidence	evidence	O	O
of	of	O	O
viral	viral	O	O
infection	infection	O	S_disease
,	,	O	O
and	and	O	O
a	a	O	O
liver	liver	O	O
biopsy	biopsy	O	O
sample	sample	O	O
showed	showed	O	O
a	a	O	O
histologic	histologic	O	O
pattern	pattern	O	O
consistent	consistent	O	O
with	with	O	O
drug-induced	drug-induced	O	O
hepatitis	hepatitis	O	S_disease
.	.	O	O

Both	both	O	O
patients	patients	O	O
recovered	recovered	O	O
quickly	quickly	O	O
after	after	O	O
stopping	stopping	O	O
glyburide	glyburide	O	O
therapy	therapy	O	O
and	and	O	O
have	have	O	O
remained	remained	O	O
well	well	O	O
for	for	O	O
a	a	O	O
follow-up	follow-up	O	O
period	period	O	O
of	of	O	O
1	1	O	O
year	year	O	O
.	.	O	O

Glyburide	glyburide	O	O
can	can	O	O
produce	produce	O	O
an	an	O	O
acute	acute	O	B_disease
hepatitis-like	hepatitis-like	O	I_disease
illness	illness	O	I_disease
in	in	O	O
some	some	O	O
persons	persons	O	O
.	.	O	O

